Insider Selling: Homology Medicines (BATS:FIXX) Insider Sells $46,334.88 in Stock

Homology Medicines, Inc. (BATS:FIXX) insider Shelia Violette sold 2,798 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $16.56, for a total transaction of $46,334.88. Following the completion of the transaction, the insider owned 127,771 shares of the company’s stock, valued at approximately $2,115,887.76. The trade was a 2.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Homology Medicines Price Performance

BATS FIXX traded down $0.16 during trading hours on Thursday, reaching $12.73. 978 shares of the company’s stock traded hands, compared to its average volume of 1,230. Homology Medicines, Inc. has a 52-week low of $12.02 and a 52-week high of $14.30.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.